Bölümler
-
In this episode of AbbottTalks, Jennifer Jones-McMeans, PhD, Divisional VP of Global Clinical Affairs at Abbott and Brian DeRubertis, MD, Chief, Division of Vascular & Endovascular Surgery at Weill Cornell Medical Center tackle the complexities of treating peripheral arterial disease (PAD) below the knee, particularly chronic limb-threatening ischemia (CLTI), a severe form of PAD that drastically impacts patients' quality of life and longevity.
In the episode, the two discuss Abbott's Esprit BTK System, the first-and-only FDA-approved drug-eluting resorbable scaffold for infrapopliteal CLTI. Dr. Jones-McMeans explains how Esprit BTK works by releasing a drug that prevents artery re-narrowing, crucial for maintaining sustained blood flow and promoting wound healing.
Later, they walk us through the pivotal LIFE-BTK trial, a significant milestone that demonstrated Esprit's efficacy and led to its FDA approval. They also highlight the importance of including diverse patient populations in clinical trials, particularly those disproportionately affected by PAD, such as African Americans, Latinos, Native Americans, and women. This inclusive approach not only ensures the treatment's effectiveness across varied demographics but also sets a precedent for future trials.
Thank you to Freudenberg Medical for sponsoring this episode of AbbottTalks. For more information on how Freudenberg Medical works with medical device companies, visit www.freudenbergmedical.com.
Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode. -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi chats with Managing Editor Kayleen Brown about the upcoming DeviceTalks West meeting. This week’s episode features an interview Brown did with Medtronic’s Nina Goodheart at the Women in Medtech Breakfast at DeviceTalks Boston. The conversation previews the Women in Medtech Luncheon interview featuring Cecilia Soriano, president, infusion therapies and technologies, at Baxter International. In our second interview, Salemi interviews Kirsten Carroll, CEO of Kandu Health about that company’s work to empower stroke survivors. Carroll will be speaking at DeviceTalks West.
Register at West.DeviceTalks.com to register. Use the code DTPOD25 to save 25%.
Subscribe now to the DeviceTalks Podcast Network. -
Eksik bölüm mü var?
-
In this episode of DeviceTalks Weekly podcast, Host Tom Salemi introduces one DeviceTalks West speaker. Ray Baker, MD, vice president and chief medical officer, neuromodulation at Boston Scientific, introduces DeviceTalks Weekly listeners to Intracept, a procedure approved by the FDA to treat forms of back pain. Dr. Baker will be a speaker at DeviceTalks West on Oct. 17 where the clinical and commercial details will be discussed.
Register now at West.Devicetalks.com. Use the code mentioned in the podcast to save 25% off the price of registration.
Salemi also invites listeners to attend the Connected Health Series taking place Sept. 10-12. Sponsored by Maxon and S3 Connected Health, virtual attendees can hear from Adona Medical, Baxter, BD and Canary Medical about the future of sensors and other connected technologies.
MassDevice Editor Chris Newmarker brings another batch of Newmarker’s Newsmakers including Novocure, Medtronic, Johnson & Johnson MedTech, Edwards Lifesciences and the Big 100.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this episode of the DeviceTalks Weekly podcast, HighRidge Medical CEO Rebecca Whitney and Executive Chairman Eric Major introduce us to the spine industry’s newest player. HighRidge combines the former spinal business of Zimmer Biomet (and later ZimVie) with seasoned executive spirit from K2M, Stryker and others. Can HighRidge compete? Will robotics and other tech be part of the story? Whitney has been on podcasts before. Listen here https://www.youtube.com/watch?v=6xtHK-FVeec and here https://youtu.be/0Ve_7NpIauQ?si=Wp-ytFHlq4ZWHeCC.
Host Tom Salemi and DeviceTalks Editor Kayleen Brown chat with MedtechVISION co-chairs Kate Stephenson, PhD, and Shelia Shah about the upcoming conference organized by the MedtechWOMEN group. A few spaces are still available. Go to MedtechWOMEN.org to register.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this episode of DeviceTalks AI, host Kayleen Brown sits down with Eigil Samset, PhD, General Manager for Cardiology Care at GE HealthCare. Dr. Samset takes us through his vast experience stretching over nearly three decades and discusses the transformative role of AI in advancing healthcare, particularly how GE HealthCare is leveraging AI to streamline and enhance cardiology care pathways.
In the episode, Dr. Samset gives us the backstory of the 2023 Caption Health acquisition and provides insights into the inspiration behind Caption AI for use in Vscan, which democratizes cardiac assessments by making them accessible to less experienced users. The conversation touches on the regulatory challenges, the importance of multi-disciplinary collaboration, and GE HealthCare's strategic approach to integrating AI – aiming to improve patient outcomes and care pathways significantly.
This conversation comes to you courtesy of our episode sponsor, DeviceTalks West. Listen to the episode for 25% OFF the registration rate: West.DeviceTalks.com.
Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode.
Thank you for listening to DeviceTalks AI! -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Tasneem Dohadwala, founding partner at Excelestar Ventures about how the small firm employs analytics, know-how, and a belief that companies are best led by diverse management teams.
MassDevice Editor Chris Newmarker returns with his Newmarker's Newsmakers including outgoing FDA CDRH Leader Jeff Shuren, the New York Times, Medtronic, Zoll Medical, Vyaire Medical, Johnson & Johnson MedTech, V-Wave, and Edwards Lifesciences.
This episode is sponsored by DeviceTalks West. Listen to the podcast to hear the discount code that will save you 25% of the price of registration. Go to West.DeviceTalks.com.
We’ll also hear a message from regulatory firm MedTech Impact Partners.
Thank you for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network. -
In this episode of Ortho Innovation Talks, Jim Lancaster, President of Global Reconstruction at Zimmer Biomet, connects his deep roots in Warsaw, Indiana—known as the orthopedic capital of the world—with his current role in shaping the region's future as a global MedTech hub with his efforts to diversify the region's medtech industry, including the partnership with Plug and Play to attract new innovations in sensor technology and augmented reality, and by driving technical innovations at Zimmer Biomet.
Additionally, Lancaster provides an in-depth look at the development of Persona IQ, the world's first smart knee system, which integrates advanced sensor technology to monitor patient recovery. He also discusses the growing importance of cementless fixation in knee implants, highlighting Zimmer Biomet's focus on enhancing implant longevity and patient outcomes. Lastly, Lancaster discusses Zimmer Biomet's role in surgical robotics, particularly the advancements brought by the Rosa robotics platform, which includes applications for knee, hip, and even shoulder surgeries.
Please join us September 10-12th for DeviceTalks's LIVE Connected Health webinar series. Register at no cost: https://event.on24.com/wcc/r/4613481/E930EFFA706588C378BEAA97824C7CE2/5516160
Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.
Thank you for listening to the Ortho Innovation Talks podcast, featuring Zimmer Biomet! -
In the inaugural episode of our newest podcast, Structural Heart Talks, we sit down with Daveen Chopra, Corporate VP and GM of Transcatheter Mitral and Tricuspid Therapies (TMTT) at Edwards Lifesciences.
In the episode, Chopra discusses the unique challenges of advancing therapies for the mitral and tricuspid valves, which have historically been more difficult to treat than the aortic valve due to their complex and varied nature. He details Edwards Lifesciences' efforts to innovate in this space with technologies like the PASCAL valve repair system and the EVOQUE tricuspid valve replacement system, the first transcatheter tricuspid valve replacement approved in both the US and Europe.
Later, Chopra explains the importance of a focused approach at Edwards Lifesciences, where the company’s specialization in structural heart disease enables deeper knowledge and more targeted innovation. The conversation also explores the intricate process of planning and executing these advanced procedures, which require close collaboration between interventional cardiologists and echocardiographers. Chopra underscores the ongoing commitment to clinical evidence and real-world outcomes as key drivers of future success in this rapidly evolving field. Looking ahead, he emphasizes the need to increase awareness, diagnosis, and treatment rates for valve diseases, noting that many patients still go untreated due to a lack of awareness.
Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8
Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks or the Structural Heart Talks on YouTube Podcasts to ensure you never miss an episode. -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi delves into the opportunities in women’s health devices with Sofinnova Partners Managing Partner Antoine Papiernik and May Health CEO Anne Morrissey. Sofinnova invested in May Health, which is developing a device-based therapy for Polycystic ovary syndrome, a common cause of infertility. Is the financing environment for Women’s Health companies improving? What will drive investors to commit more capital.
MassDevice Editor Chris Newmarker brings his Newmarker’s Newsmakers back featuring news from NeuroOne, Pentax, Allurion, Medtronic and Abbott. Associate Editor Sean Whooley joins the NewNew team to break down the new partnership between Abbott and Medtronic in the diabetes business.
Thank you for listening to the DeviceTalks Weekly Podcast.
Subscribe now to the DeviceTalks Podcast Network. -
In this episode of IntuitiveTalks, we welcome back Myriam Curet, MD, EVP & Chief Medical Officer at Intuitive, to discuss the transformative impact of surgical robotics on patient care, focusing on the evolution of the DaVinci system, including the recent DaVinci 5 launch.
In the episode, Dr. Curet explains how surgical robotics like DaVinci have shifted from being seen as advanced technology to becoming an integral part of surgical practice, enhancing patient outcomes and surgeon efficiency. She also stresses the significance of real-world data and meta-analyses in validating surgical robotic systems and providing a profound understanding of their benefits across various categories of surgery. Lastly, Dr. Curet offers a behind-the-scenes look at the meticulous development and approval process of the DaVinci 5 system.
Thank you to Paragon Medical for sponsoring this episode of IntuitiveTalks. Please visit https://www.paragonmedical.com/ to learn more about how Paragon Medical supports medical device companies.
Thank you for listening to the IntuitiveTalks podcast. Please subscribe to DeviceTalks on all major podcast channels to never miss an episode. -
In this episode of DeviceTalks Weekly Podcast, Host Tom Salemi interviews Jim Hollingshead, PhD, the CEO of Insulet. Hollingshead had the unenviable job of taking over for CEO Shacey Petrovic when she left the insulin-delivery company two years ago. Hollingshead previously had helped ResMed develop its industry-leading connectivity/cloud strategy. In this conversation you’ll hear about his journey and what steps Insulet has taken to build share in the Type 1 and Type 2 diabetes markets
MassDevice Editor Chris Newmaker returns with his newsmakers - Asensus Surgical, Tandem, Stryker, Perceptive, and BiVacor.
This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don't miss a future episode. -
In this episode of the DeviceTalks Weekly, Chris Landon returns to the podcast but this time as CEO of Natus Neuro, a company building out a monitoring, diagnostics and data collection platform to help diagnose and treat neurological disorders.
This episode is sponsored by DeviceTalks West.
Host Tom Salemi and Chris Newmarker, editor of MassDevice, review this week’s Newmaker’s Newsmakers - aka the week’s biggest medtech stories. Top newsmakers include Imperative Care, the FDA, neuro start-Ups, Inspire Medical and Edwards Lifesciences.
Thanks for listening to this episode of the DeviceTalks Weekly Podcast.
Subscribe now to the DeviceTalks Podcast Network. -
In this episode of AbbottTalks, Matthew Fishler, PhD, Chief Engineer & Senior Director, Product Development, Cardiac Rhythm Management at Abbott Cardiovascular, shares his experience helping to develop the revolutionary dual-chamber leadless pacemaker system, taking us through the significant challenges and triumphs of creating a device that ensures precise coordination between the heart’s atrial and ventricular chambers without traditional leads.
Fishler recounts the meticulous development process, from initial concept testing using rudimentary "submarines" in saline tanks to achieving FDA approval. He highlights the deliberate approach taken to ensure safety and effectiveness, resulting in a device that now benefits patients with more comprehensive cardiac support. Lastly, he explains the innovative i2i communication technology, which uses electrical impulses to enable seamless device interaction, a concept likened to a “moonshot” due to its unprecedented nature.
Thank you to ProMed for sponsoring this episode of AbbottTalks. To learn more about ProMed’s prototype services, visit: https://promedmolding.com/capabilities/prototyping/
Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode. -
In this week’s DeviceTalks Weekly Podcast, Host Tom Salemi talks with Endotronix CEO Harry Rowland about the company’s long road to securing PMA approval from the FDA for its Cordella Pulmonary Artery (PA) Sensor System for the treatment of heart failure patients.
But first we welcome back the Newmarker’s Newsmakers! MassDevice Editor-in-Chief Chris Newmarker highlights news from Masimo, Stryker, Medtronic, ICU Medical and Edwards Lifescience.
This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com.
Thank you for listening to the DeviceTalks Weekly podcast.
Subscribe now to the DeviceTalks Podcast Network. -
In this episode of StrykerTalks, we welcome back Andy Pierce, Group President of MedSurg and Neurotechnology, to discuss the impact of the Vocera acquisition and how Vocera's dynamic clinical workflow addresses staffing shortages and enhances efficiency.
Additionally, the episode covers Stryker's new LIFEPAK 35 monitor/defibrillator, advancements in the 1788 visualization platform, and ongoing innovations in the neurovascular space. Pierce also touches on plans for incorporating Vocera into more Stryker products and the company's interest in soft-tissue surgical robotics.
Want more from Andy Pierce? Explore his previous appearances on the DeviceTalks Podcast Network.
Prior appearance on StrykerTalks:
https://www.devicetalks.com/pierce-talks-innovation-vocera-ascs-and-why-nurses-hug-strykers-neptune-waste-management-system/
Prior appearance on DT Weekly:
https://www.devicetalks.com/lobo-and-pierce-talk-wright-cool-tech-robotics-and-the-not-so-secret-plans-to-keep-stryker-growing/
Thank you to S2 Insight, Inc. for sponsoring this episode. To learn more about how S2 Insight, Inc. supports medical device companies, visit https://www.s2insight.com/case-studies.
Thank you for listening to the StrykerTalks Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Powell, CEO and president of RefleXion, maker of a smart radiotherapy system used to combat cancer. Powell talks about his path into MedTech and how the company’s ScinTix system can “debulk” widespread cancer in patients.
This episode is sponsored by the DeviceTalks West conference taking place Oct. 16-17 at the Santa Clara Convention Center. Register at West.DeviceTalks.com
Thank you for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this episode of DeviceTalks AI, we explore the advancements in AI-driven technologies in women's health and cancer diagnostics.
In our keynote interview, we speak with Michael Quick, Vice President of R&D and Innovation in Cytology & Oncology at Hologic. Quick shares his journey from a pre-med student to a leader in cytology innovation. He discusses the development and impact of Hologic’s Genius Digital Diagnostic Systems, the first FDA-approved digital cytology system, which leverages AI to enhance cervical cancer screening accuracy and efficiency. Michael emphasizes Hologic’s dedication to women's health and the critical role of AI in addressing the shortage of skilled cytologists, ensuring faster and more accurate diagnostics for patients worldwide. He also touches on the challenges and opportunities faced during the FDA approval process and the importance of early and collaborative engagement with regulatory bodies.
We also hear from Dr. Wael Yared, Chief Technology Officer at Tecan, who highlights Tecan's contributions to cancer research and diagnostics. Dr. Yared elaborates on the company's innovations in liquid biopsy and solid tissue biopsy workflows, which leverage AI to streamline processes and reduce errors. He emphasizes the significance of partnerships in driving medical advancements and the role of AI in personalized medicine and multiomic capabilities.
This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about Tecan visit, https://partnering.tecan.com
Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode.
Thank you for listening to DeviceTalks AI! -
In this episode of Device Talks Weekly Podcast, Host Tom Salemi breaks down the recent Society of Robotic Surgery annual meeting with industry experts Steve Bell and Joe Mullings of The Mullings Group. The discussion ranges beyond the meeting into the state of Surgical Robotics.
This episode is sponsored by DeviceTalks West. Go to West.DeviceTalks.com for more information.
Thanks for listening to this episode of the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi speaks with Dr. Janar Sathananthan, chief medical officer of Boston Scientific’s interventional cardiology therapies business about the coronary artery disease, stenting and its AGENT drug-coated balloon.
This episode is sponsored by Freudenberg Medical. For more information, please visit www.freudenbergmedical.com.
MassDevice’s Chris Newmarker and Sean Whooley join the Newmarker’s Newsmakers section to talk about the big MedTech story of the week as well as the news coming out of the American Diabetes Association annual meeting.
Salemi also shares some thoughts from the Annual Meeting of the Society of Robotic Surgery.
Thank you for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode. -
In this episode of the DeviceTalks Weekly podcast, Kevin Chaplin, CEO of Kardium, a Vancouver-based electrophysiology device company, shares details of the company’s Globe® Pulsed Field Mapping and Ablation System. With $100 million in new capital, the company is poised to open a new front in the pulsed-field ablation battle.
Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information.
Thank you for listening to the DeviceTalks Weekly Podcast.
Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode. - Daha fazla göster